Literature DB >> 26176566

Inhibition of B-cell apoptosis is mediated through increased expression of Bcl-2 in patients with rheumatoid arthritis.

Jin Yang1, Shaolin Zhao1, Xinling Yang2, Huanhuan Zhang1, Ping Zheng1, Huiyi Wu1.   

Abstract

AIM: Abnormal B-cell apoptosis is believed to have a role in rheumatoid arthritis (RA) pathogenesis, but the exact mechanisms of B-cell apoptosis in RA have not been elucidated. We therefore investigated the percentage of circulating B cells and its relationship with apoptosis in a cohort of patients with RA.
METHODS: B cells were quantified by flow cytometry in RA patients and matched controls, and the relationships between these proportions and RA disease parameters were calculated. Rates of apoptosis were determined by annexin V/propidium iodine analysis, and Bcl-2 and caspase-3 protein levels were determined by western blot.
RESULTS: RA patients had significantly higher percentage of B cells in the peripheral blood than healthy controls but a significantly lower rate of B-cell apoptosis. The percentage of B cells correlated with Disease Activity Score of 28 joints and serum immunoglobulin G concentration in RA patients. Expression of anti-apoptosis protein Bcl-2 was higher in RA patients than in healthy controls, whereas expression of apoptosis marker caspase-3 in B cells was lower.
CONCLUSION: The higher percentage of B cells in the peripheral blood of RA patients may be due, at least partially, to disruption of the normal pathway of apoptosis in these cells. The inhibition of B-cell apoptosis in these patients may be attributable to the enhanced expression of Bcl-2 in these cells.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  B cell; Bcl-2; apoptosis; caspase-3; rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26176566     DOI: 10.1111/1756-185X.12706

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  8 in total

1.  The level of cytokines and expression of caspase genes in rheumatoid arthritis.

Authors:  I E Malysheva; L V Topchieva; O Y Barysheva; I V Kurbatova; O A Vasykova; N N Vezikova; I M Marusenko; N N Nemova
Journal:  Dokl Biochem Biophys       Date:  2016-07-15       Impact factor: 0.788

2.  Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems.

Authors:  Pietro Gentile; John P Cole; Megan A Cole; Simone Garcovich; Alessandra Bielli; Maria Giovanna Scioli; Augusto Orlandi; Chiara Insalaco; Valerio Cervelli
Journal:  Int J Mol Sci       Date:  2017-02-14       Impact factor: 5.923

Review 3.  Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.

Authors:  Pietro Gentile; Simone Garcovich
Journal:  Cells       Date:  2019-05-16       Impact factor: 6.600

Review 4.  PKM2: A Potential Regulator of Rheumatoid Arthritis via Glycolytic and Non-Glycolytic Pathways.

Authors:  Danyi Xu; Junyu Liang; Jin Lin; Chaohui Yu
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

Review 5.  What Will B Will B: Identifying Molecular Determinants of Diverse B-Cell Fate Decisions Through Systems Biology.

Authors:  Simon Mitchell
Journal:  Front Cell Dev Biol       Date:  2021-01-12

6.  Network analysis indicating the pharmacological mechanism of Yunpi-Qufeng-Chushi-prescription in prophylactic treatment of rheumatoid arthritis.

Authors:  Lin Li; Donghai Zhou; Qiuping Liu; Dianming Li; Qiao Wang; Xiaowei Shi; Chengping Wen; Lin Huang
Journal:  BMC Complement Med Ther       Date:  2021-05-15

Review 7.  The Role of PKC and HIF-1 and the Effect of Traditional Chinese Medicinal Compounds on Cerebral Ischemia-Reperfusion Injury.

Authors:  Zheyu Fang; Yangyang Zhang; Xixi Zhao; Weifeng Jin; Li Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-27       Impact factor: 2.629

8.  B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.

Authors:  Rita A Moura; Cláudia Quaresma; Ana R Vieira; Maria J Gonçalves; Joaquim Polido-Pereira; Vasco C Romão; Nádia Martins; Helena Canhão; João E Fonseca
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.